92 related articles for article (PubMed ID: 27793881)
21. CDK9 is dispensable for YAP-driven hepatoblastoma development.
Chen X; Kiss A; Schaff Z; Evert K; Zhang Y; Zhong S; Wang J; Evert M; Calvisi DF; Chen X
Pediatr Blood Cancer; 2020 May; 67(5):e28221. PubMed ID: 32124532
[TBL] [Abstract][Full Text] [Related]
22. Cross talk between RNA N6-methyladenosine methyltransferase-like 3 and miR-186 regulates hepatoblastoma progression through Wnt/β-catenin signalling pathway.
Cui X; Wang Z; Li J; Zhu J; Ren Z; Zhang D; Zhao W; Fan Y; Zhang D; Sun R
Cell Prolif; 2020 Mar; 53(3):e12768. PubMed ID: 31967701
[TBL] [Abstract][Full Text] [Related]
23. m
Liu L; Wang J; Sun G; Wu Q; Ma J; Zhang X; Huang N; Bian Z; Gu S; Xu M; Yin M; Sun F; Pan Q
Mol Cancer; 2019 Dec; 18(1):188. PubMed ID: 31870368
[TBL] [Abstract][Full Text] [Related]
24. GREB1 induced by Wnt signaling promotes development of hepatoblastoma by suppressing TGFβ signaling.
Matsumoto S; Yamamichi T; Shinzawa K; Kasahara Y; Nojima S; Kodama T; Obika S; Takehara T; Morii E; Okuyama H; Kikuchi A
Nat Commun; 2019 Aug; 10(1):3882. PubMed ID: 31462641
[TBL] [Abstract][Full Text] [Related]
25. β-Catenin and Yes-Associated Protein 1 Cooperate in Hepatoblastoma Pathogenesis.
Min Q; Molina L; Li J; Adebayo Michael AO; Russell JO; Preziosi ME; Singh S; Poddar M; Matz-Soja M; Ranganathan S; Bell AW; Gebhardt R; Gaunitz F; Yu J; Tao J; Monga SP
Am J Pathol; 2019 May; 189(5):1091-1104. PubMed ID: 30794807
[TBL] [Abstract][Full Text] [Related]
26. Transcription factor GATA4 associates with mesenchymal-like gene expression in human hepatoblastoma cells.
Soini T; Eloranta K; Pihlajoki M; Kyrönlahti A; Akinrinade O; Andersson N; Lohi J; Pakarinen MP; Wilson DB; Heikinheimo M
Tumour Biol; 2018 Jul; 40(7):1010428318785498. PubMed ID: 30074440
[TBL] [Abstract][Full Text] [Related]
27. Comprehensive analysis and experimental verification of LINC01314 as a tumor suppressor in hepatoblastoma.
Lv B; Zhang L; Miao R; Xiang X; Dong S; Lin T; Li K; Qu K
Biomed Pharmacother; 2018 Feb; 98():783-792. PubMed ID: 29571247
[TBL] [Abstract][Full Text] [Related]
28. A novel tissue-based ß-catenin gene and immunohistochemical analysis to exclude familial adenomatous polyposis among children with hepatoblastoma tumors.
Dubbink HJ; Hollink IHIM; Avenca Valente C; Wang W; Liu P; Doukas M; van Noesel MM; Dinjens WNM; Wagner A; Smits R
Pediatr Blood Cancer; 2018 Jun; 65(6):e26991. PubMed ID: 29446530
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA therapy inhibits hepatoblastoma growth
Indersie E; Lesjean S; Hooks KB; Sagliocco F; Ernault T; Cairo S; Merched-Sauvage M; Rullier A; Le Bail B; Taque S; Grotzer M; Branchereau S; Guettier C; Fabre M; Brugières L; Hagedorn M; Buendia MA; Grosset CF
Hepatol Commun; 2017 Apr; 1(2):168-183. PubMed ID: 29404451
[TBL] [Abstract][Full Text] [Related]
30. Hepatoblastoma: current understanding, recent advances, and controversies.
Czauderna P; Garnier H
F1000Res; 2018; 7():53. PubMed ID: 29375822
[No Abstract] [Full Text] [Related]
31. Downregulation of transcription factor GATA4 sensitizes human hepatoblastoma cells to doxorubicin-induced apoptosis.
Soini T; Pihlajoki M; Kyrönlahti A; Andersson LC; Wilson DB; Heikinheimo M
Tumour Biol; 2017 Mar; 39(3):1010428317695016. PubMed ID: 28349834
[TBL] [Abstract][Full Text] [Related]
32. Navigating relapsed hepatoblastoma: Predictive factors and surgical treatment strategy.
Espinoza AF; Patel KR; Shetty PB; Whitlock RS; Sumazin P; Yu X; Sarabia SF; Urbicain M; Heczey A; Masand P; Woodfield SE; López-Terrada DH; Vasudevan SA
Cancer Med; 2023 Dec; 12(23):21270-21278. PubMed ID: 37962078
[TBL] [Abstract][Full Text] [Related]
33. The Repurposing of Non-Peptide Neurokinin-1 Receptor Antagonists as Antitumor Drugs: An Urgent Challenge for Aprepitant.
Coveñas R; Rodríguez FD; Robinson P; Muñoz M
Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958914
[TBL] [Abstract][Full Text] [Related]
34. PCSK9 in Liver Cancers at the Crossroads between Lipid Metabolism and Immunity.
Alannan M; Seidah NG; Merched AJ
Cells; 2022 Dec; 11(24):. PubMed ID: 36552895
[TBL] [Abstract][Full Text] [Related]
35. Transcriptome analysis revealed the role of mTOR and MAPK signaling pathways in the white strain of
Lee KT; Chen LY; Li WS; Lee HZ
Front Pharmacol; 2022; 13():1039376. PubMed ID: 36506551
[TBL] [Abstract][Full Text] [Related]
36. Advances in the conventional clinical treatment for hepatoblastoma and therapeutic innovation.
Chen Z; Dong R
World J Pediatr Surg; 2021; 4(3):e000220. PubMed ID: 36474976
[TBL] [Abstract][Full Text] [Related]
37. Identification of Key Pathways Involved in White Strain of
Li WS; Lee KD; Chen LY; You BJ; Lee HZ
Front Pharmacol; 2022; 13():888863. PubMed ID: 35784738
[TBL] [Abstract][Full Text] [Related]
38. Childhood cancer survival and avoided deaths in Australia, 1983-2016.
Youlden DR; Baade PD; Moore AS; Pole JD; Valery PC; Aitken JF
Paediatr Perinat Epidemiol; 2023 Jan; 37(1):81-91. PubMed ID: 35672573
[TBL] [Abstract][Full Text] [Related]
39. Molecular Mechanisms of Hepatoblastoma.
Zhang Y; Solinas A; Cairo S; Evert M; Chen X; Calvisi DF
Semin Liver Dis; 2021 Jan; 41(1):28-41. PubMed ID: 33764483
[TBL] [Abstract][Full Text] [Related]
40. The Neurokinin-1 Receptor Antagonist Aprepitant: An Intelligent Bullet against Cancer?
Muñoz M; Coveñas R
Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32962202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
